Cross Shawn (CIK 1734779) reported 16 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-04-24). Recent activity: Sell PCRX (12,941 shares), Buy PCRX (12,941 shares), Buy PCRX (2,845 shares), Buy PCRX (7,714 shares), Sell PCRX (7,714 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-24 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Sell | 12,941 | $325,596 |
| 2026-04-24 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Buy | 12,941 | $212,879 |
| 2026-04-22 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Buy | 2,845 | $46,800 |
| 2026-04-22 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Buy | 7,714 | $126,895 |
| 2026-04-22 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Sell | 7,714 | $193,930 |
| 2026-04-22 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Sell | 2,845 | $71,153 |
| 2026-04-22 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Buy | 1,500 | $24,675 |
| 2026-04-22 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Sell | 1,500 | $37,515 |
| 2026-02-13 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Buy | 49,091 | $0 |
| 2025-12-11 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Buy | 15,896 | $261,489 |
| 2025-12-11 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Sell | 15,896 | $397,877 |
| 2025-12-11 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Buy | 9,104 | $149,761 |
| 2025-12-11 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Sell | 9,104 | $228,875 |
| 2025-11-13 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Sell | 12,060 | $266,405 |
| 2025-11-03 | Pacira BioSciences, Inc. (PCRX) | Chief Financial Officer | Sell | 6,690 | $143,032 |
| 2025-03-03 | Cyclo Therapeutics, Inc. (CYTH) | Director | Buy | 28,597 | $0 |
Source: SEC Form 4 filings · as of 2026-04-24